Resmed Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€212.60
Target price
31.10.26
€261.85
Performance (%)
0.61%
Price
15:13
€213.90
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Resmed Inc. is nearly unchanged. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -1.667% | -1.667% |
| iShares Core DAX® | 1.130% | 2.184% |
| iShares Nasdaq 100 | 1.128% | -0.611% |
| iShares Nikkei 225® | 2.610% | 4.958% |
| iShares S&P 500 | -0.006% | -0.952% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat